Renal Outcomes of Cardiovascular SGLT-2 Inhibitors Trials

Jagdeesh Ullal, MD, explains chronic kidney disease in diabetes and summarizes the findings of SGLT-2 inhibitor CVOT and kidney outcomes.

Educational Objectives

Upon completion of this activity, participants should be able to: 

  • Explain chronic kidney disease in diabetes
  • Recognize the interplay between cardiovascular disease and chronic kidney disease in diabetes
  • Summarize the findings of SGLT-2 inhibitor CVOT and kidney outcomes

Disclosures

Dr. Ullal has reported no relevant relationships with entities producing health care goods or services.

All presenters' disclosures of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients is listed above. No other planners, members of the planning committee, speakers, presenters, authors, content reviewers, and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

Accreditation Statement

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh designates enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit[s]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

For your credit transcript, please access our website four weeks postcompletion at http://ccehs.upmc.com and follow the link to the Credit Transcript page.

Release Date: 4/9/2021 | Last Modified On: 4/9/2021 | Expires: 4/11/2022